Purpose of the Procedure
- Assessing the likelihood of malignant ovarian tumors.
- Assisting surgeons in planning surgeries for pelvic masses.
- Improving diagnostic accuracy compared to using CA-125 alone.
Book ROMA Score Test in Saudi Arabia | Lahalak Medical Platform
Protect your health with early detection; the ROMA score combines HE4 and CA-125 markers to accurately assess ovarian malignancy risk, providing essential insights for surgical planning and effective clinical management.
Scientific name: Risk of Ovarian Malignancy Algorithm (ROMA Score)
A specialized laboratory test measuring HE4 and CA-125 protein levels. It calculates the probability of ovarian malignancy in women with pelvic masses, assisting surgeons in preoperative planning and risk assessment.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Human Epididymis Protein 4 (HE4) Test
- Cancer Antigen 125 (CA-125) Test
- ROMA Algorithm Calculation
Medical Service Information
Target Groups
- Women diagnosed with a pelvic mass.
- Women with a family history of ovarian cancer.
- Patients requiring precise preoperative risk stratification.
Important Information
- The result is a risk assessment, not a definitive cancer diagnosis.
- Results must be discussed with an oncologist or gynecologist.
- Calculations differ based on the patient's hormonal/menopausal status.
Conditions & Notices
- Menopausal status must be specified (pre-menopausal or post-menopausal)
Medical services you might also like
